ZURA (ZURA) Stock Price & Analysis
ZURA (ZURA) fell 1.60% to USD 6.13 as of September 9, 2026 at 12:05 UTC, according to Nexqual real-time market data.
ZURA last closed at USD 6.13; the session ranged USD 5.9–6.23 on volume of 1,616,430 shares. Market capitalization is —, with a 52-week range of USD 1.88–7.44 (NCM). Source: Nexqual, September 9, 2026 at 12:05 UTC.
Key Statistics (as of September 9, 2026 at 12:05 UTC)
| Price | USD 6.13 |
|---|---|
| Change | ▼ 1.60% (down) |
| Previous Close | USD 6.13 |
| Open | USD 6.13 |
| Day Range | USD 5.9 – 6.23 |
| 52-Week Range | USD 1.88 – 7.44 |
| Volume | 1,616,430 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ZURA)
Nexqual's technical model rates ZURA "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 12:05 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.91 (neutral) |
| vs SMA50 | Above (USD 5.59) |
| MACD | 0.13 (positive) |
From ZURA's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | USD 0.34 | ▼ 7.06% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 14.27 | ▼ 0.76% |
| PEPG | PepGen Inc. | USD 3.21 | ▲ 0.94% |
| TNGX | Tango Therapeutics, Inc. | USD 22.7 | ▼ 0.26% |
| ACRV | Acrivon Therapeutics, Inc. | USD 2.1 | ▲ 1.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:05 UTC. This page is informational and not investment advice.